Unisciti agli esperti di The Lancet Oncology per discutere ricerche significative e le loro implicazioni su trattamenti per il cancro e accesso alle cure.
Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA)
8 mins • Mar 31, 2025
Charts
- 184NEW
- 179NEW
- 162Decreased by 144
- 182NEW
- 76Increased by 59
Episodi recenti

Mar 31, 2025
Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA)
8 mins

Mar 3, 2025
Ariana Znaor on cancer surveillance in the Eastern Mediterranean region
20 mins

Feb 3, 2025
Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials
18 mins

Jan 2, 2025
Yannick Romero on the changing landscape of national cancer control plans
25 mins

Dec 2, 2024
M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries
22 mins

Lingua
Inglese
Paese
Stati Uniti
Feed Host
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.